Philip Kern
Clinical trials sponsored by Philip Kern, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a bladder drug and an ED drug fix prediabetes? Results expected Jan 2027 (estimated)
- Could a bladder pill help prevent diabetes? Results expected Jun 2027 (estimated)
-
Could a bladder drug and an ED drug fix prediabetes?
Disease control Recruiting nowThis study tests whether mirabegron (a bladder medication) and tadalafil (used for erectile dysfunction) can improve blood sugar control in people with prediabetes and obesity. About 96 adults will take one or both drugs or a placebo for 14 weeks. The goal is to see if these drug…
Phase 4 • Sponsor: Philip Kern • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a bladder pill help prevent diabetes?
Disease control Recruiting nowThis phase 2 trial is testing whether mirabegron, a drug currently used for overactive bladder, can improve glucose tolerance and activate brown fat in people with prediabetes. Researchers will enroll 65 adults with a BMI of 27-45 and prediabetes. Participants will take mirabegro…
Phase 2 • Sponsor: Philip Kern • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC